Inflammatory and anti‐inflammatory cytokines in chronic heart failure: Potential therapeutic implications

By Aukrust Pål   Gullestad Lars   Ueland Thor   Damås Jan   Yndestad Arne  

Annals of Medicine, Vol. 37, Iss. 2, 2005-04 ,pp. : 74-85

Informa Healthcare

Access to resources Recommend Favorite

Relaxin: A Novel Agent for the Treatment of Acute Heart Failure

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 3, 2015-03 ,pp. : 315-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Ion channels as novel therapeutic targets in heart failure

By Akar Fadi   Tomaselli Gordon  

Annals of Medicine, Vol. 37, Iss. 1, 2005-03 ,pp. : 44-54

Informa Healthcare

Access to resources Recommend Favorite

Increased pulmonary vascular resistance, right ventricular dysfunction, and reversible pulmonary vasoconstriction in type 2 pulmonary hypertension: who has it and are we missing a potential therapeutic target in patients with heart failure?

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 3, 2015-03 ,pp. : 237-238

John Wiley & Sons Inc

Access to resources Recommend Favorite

Beta-adrenergic Signaling: Complexities and Therapeutic Relevance to Heart Failure

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 2, 2012-04 ,pp. : 120-131

Bentham Science Publishers

Access to resources Recommend Favorite